Related Experiment Video
Updated: May 3, 2026

10:35
DNA-magnetic Particle Binding Analysis by Dynamic and Electrophoretic Light Scattering
Published on: November 9, 2017
11.2K
Magnetic nanoparticle clusters as actuators of ssDNA release
M Banchelli1, S Nappini, C Montis
1Department of Chemistry "Ugo Schiff" and CSGI, University of Florence, 50019 Florence, Italy. piero.baglioni@unifi.it.
Physical Chemistry Chemical Physics : PCCP
|February 4, 2014
Summary
Researchers developed a novel nanomedicine approach using magnetic nanoparticles for controlled DNA release. Applying an alternating magnetic field triggers drug release, enhancing targeted nucleic-acid based therapy.
Area of Science:
- Nanomedicine
- Biotechnology
- Materials Science
Background:
- Developing remotely controllable drug delivery systems is crucial in nanomedicine.
- Challenges remain in achieving selectivity and avoiding off-target interactions.
- Existing methods for nucleic acid delivery require improved control and safety.
Purpose of the Study:
- To present an innovative method for controlled DNA release using core-shell magnetic nanoparticles.
- To demonstrate remote actuation of drug release via external magnetic fields.
- To explore new possibilities for nucleic-acid based therapies.
Main Methods:
- Functionalizing core-shell magnetic nanoparticles with single-stranded oligonucleotides.
- Inducing nanoparticle clusterization through complementary strand hybridization.
- Applying a low-frequency (6 KHz) alternating magnetic field to trigger DNA melting and release.
Main Results:
- Successful clusterization of magnetic nanoparticles mediated by DNA hybridization.
- Demonstrated remote, magnetically induced release of DNA strands.
- Showcased the potential for localized control over drug delivery.
Conclusions:
- The developed system offers a novel approach for remotely controlled nucleic acid delivery.
- Magnetic nanoparticle steering and triggered release open new avenues in targeted therapy.
- This technology holds promise for advancing nucleic-acid based therapeutic strategies.

